Stocks and Investing Stocks and Investing
Tue, October 17, 2023
Mon, October 16, 2023
Sun, October 15, 2023
Fri, October 13, 2023

Allison Bratzel Initiated (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023


Published on 2024-10-28 06:52:52 - WOPRAI, Allison Bratzel
  Print publication without navigation


Allison Bratzel of Piper Sandler, Initiated "AbCellera Biologics Inc." (ABCL) at Buy and Held Target at $20 on, Oct 13th, 2023.

Allison has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Allison's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Allison


  • Robert Wasserman of "Benchmark" Maintained at Strong Buy with Decreased Target to $12 on, Thursday, August 31st, 2023
  • Andrea Tan of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $24 on, Friday, August 4th, 2023